Improving Medication Safety with Accurate Preadmission Medication Lists and Postdischarge Education
Abstract:Background: Gathering a complete preadmission medication list (PAML) at admission remains an essential component of medication reconciliation, as is providing the patient with a written medication list at the time of hospital discharge. A medication reconciliation project was begun in 2007 at an integrated health care system to (1) improve the accuracy of PAMLs within 24 hours of admission for patients admitted through the emergency department (ED) and (2) enhance patient education through telephone calls by pharmacists to the patients most at risk for adverse drug events (ADEs) or readmission.
Accuracy of PAMLs: In the October 2007–May 2008 period, RN-generated PAMLs were accurate 16% of the time versus 89% for the June 2008–December 2010 period, when they were generated by pharmacy technicians. Medication errors classified as having the potential to cause moderate or serious harm decreased from 13.17% to 1.50%.
Postdischarge Education of Complex Patients by Pharmacists: By summer 2009, the Safe Med pharmacist program was fully staffed, thereby enabling the program to contact nearly 100% of the 10,174 patients meeting the Safe Med criteria from January 2009 through December 2010. When compared with historical controls, the Safe Med intervention was associated with a statistically significant reduction in 30- and 60-day readmissions, ADE–associated 30- and 60-day readmissions, and 30- and 60-day ED visits.
Conclusions: ED–deployed pharmacy personnel can enhance the accuracy of PAMLs and may thereby reduce in-hospital ADEs. The postdischarge intervention by pharmacists with the most complex patients may reduce ADEs following hospital discharge. The interventions may compensate for discontinuities in care and lessen the attendant threats to patient safety.
Document Type: Research Article
Publication date: 2012-10-01
More about this publication?
- The Joint Commission Journal on Quality and Patient Safety will be published by Elsevier beginning in 2017! For readers who receive access to the journal through their institutions, the journal can now be found on ScienceDirect (http://www.sciencedirect.com/science/journal/15537250). For librarians looking to subscribe to the journal for their institutions please contact your Elsevier Account Manager or visit www.myelsevier.com for more information. All other readers, please visit http://www.jointcommissionjournal.com/ to subscribe to the journal or to claim your access for an existing subscription.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Information for Advertisers
- Reprints and Permissions
- Ingenta Connect is not responsible for the content or availability of external websites